Literature DB >> 8490183

Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.

H Shen1, M Clauss, J Ryan, A M Schmidt, P Tijburg, L Borden, D Connolly, D Stern, J Kao.   

Abstract

Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is a polypeptide mediator, elaborated by certain tumors and other cell types, that exerts multiple effects on endothelium via interaction with a class of high-affinity binding sites. In this report, the interaction of VPF/VEGF with human mononuclear phagocytes (MPs) is characterized. Radioligand binding studies at 4 degrees C showed the presence of a single class of binding sites, kd approximately 300 to 500 pmol/L (approximately 20 times lower affinity than the high-affinity binding site on endothelial cells [ECs]), the occupancy of which correlated with VPF/VEGF-induced MP migration and expression of tissue factor. These binding results were paralleled by functional experiments which indicated that the same VPF/VEGF preparations were about an order of magnitude less effective in stimulating MP chemotaxis than in inducing EC proliferation. When MPs with surface-bound 125I-VPF/VEGF were warmed to 37 degrees C, endocytosis and degradation occurred. Occupancy of VPF/VEGF binding site resulted in subsequent activation of intracellular signal transduction mechanisms, as shown by an increase in MP intracellular calcium concentration. Cross-linking studies with 125I-VPF/VEGF showed a new high-molecular weight band (corresponding to putative 125I-VPF/VEGF-receptor complex), the appearance of which was blocked by excess unlabeled VPF/VEGF. Consistent with these results, immunoprecipitation of 32PO4-labeled MPs exposed to VPF/VEGF showed a single band of similar mobility, not seen in untreated controls. These results demonstrate that the interaction of VPF/VEGF with MPs, though of lower affinity than that observed with ECs, also results from interaction of the polypeptide with a specific cell-surface protein and leads to activation of intracellular transduction mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490183

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.

Authors:  Y Moromizato; S Stechschulte; K Miyamoto; T Murata; A Tsujikawa; A M Joussen; A P Adamis
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

Review 3.  Angiogenesis and vasculogenesis in treatment of cardiovascular disease.

Authors:  A Rivard; J M Isner
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

4.  Soluble vascular endothelial growth factor (VEGF) receptor-1 inhibits migration of human monocytic THP-1 cells in response to VEGF.

Authors:  Cansheng Zhu; Zhaojun Xiong; Xiaohong Chen; Zhengqi Lu; Guoyu Zhou; Dunjing Wang; Jian Bao; Xueqiang Hu
Journal:  Inflamm Res       Date:  2011-04-13       Impact factor: 4.575

5.  Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes.

Authors:  T Griga; S Werner; M Köller; A Tromm; B May
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

6.  VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy.

Authors:  M I Hobson; C J Green; G Terenghi
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

7.  VEGF polymorphisms and severity of atherosclerosis.

Authors:  W M Howell; S Ali; M J Rose-Zerilli; S Ye
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

8.  Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).

Authors:  K Miyamoto; S Khosrof; S E Bursell; Y Moromizato; L P Aiello; Y Ogura; A P Adamis
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 9.  Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis.

Authors:  Gavin Thurston; Nicholas W Gale
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

10.  VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.

Authors:  Claus Cursiefen; Lu Chen; Leonardo P Borges; David Jackson; Jingtai Cao; Czeslaw Radziejewski; Patricia A D'Amore; M Reza Dana; Stanley J Wiegand; J Wayne Streilein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.